# Lexeo Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/lexeo-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 26 | | Claims under review | 1 | | Evidence records | 9 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-06T04:46:47.792621+00:00 | | Last reviewed | 2026-10-06T04:46:47.792621+00:00 | ## Identity - Legal name: Lexeo Therapeutics, Inc. - Display name: Lexeo Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-06T20:04:15.079136+00:00 | | Completeness | 0.364 | | Record Quality | 0.814 | | Directors | 12 | | Committees | 0 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Brenda Cooperstone: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:6 - Laura Sepp-Lorenzino: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-01. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:8 - Mette Kirstine Agger: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:10 - Paula HJ Cholmondeley: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:11 - Reinaldo Diaz: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2005-01-01. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:13 - Steven Altschuler: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2012-01-01. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:14 - Tim Van Hauwermeiren: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:15 - Tolga Tanguler: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:16 - Brenda Cooperstone, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:7 - Laura Sepp-Lorenzino, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:9 - R. Nolan Townsend: Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:12 - Steven Altschuler, M.D.: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:5 ## Executive leadership - Jose Manuel Otero: Chief Operating Officer [COO]. Status: current. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:19 - Narinder P. Bhalla: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:24 - Eric Adler, M.D.: Chief Medical Officer and Head of Research. Status: unknown. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:17 - Jenny R. Robertson, J.D.: Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:18 - Jose Manuel Otero, Ph.D.: Chief Operating Officer [COO]. Status: unknown. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:20 - Kyle Rasbach, Ph.D.: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:21 - Louis Tamayo: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:22 - Narinder Bhalla, M.D.: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:23 - R. Nolan Townsend: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:25 - Sandi See Tai, M.D.: Chief Development Officer. Status: unknown. claim_id=alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:26 ## Governance events - EXECUTIVE_APPOINTED: Jose Manuel Otero executive of Lexeo Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:executive_appointed:17vmh3b - EXECUTIVE_APPOINTED: Narinder P. Bhalla executive of Lexeo Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:executive_appointed:1ak6jfq - DIRECTOR_APPOINTED: Laura Sepp-Lorenzino seat on Lexeo Therapeutics, Inc., effective 2026-01-01. Effective: 2026-01-01. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:director_appointed:18qlcal - DIRECTOR_APPOINTED: Tim Van Hauwermeiren seat on Lexeo Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:director_appointed:1u4luuz - DIRECTOR_APPOINTED: Tolga Tanguler seat on Lexeo Therapeutics, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:director_appointed:1lrgjo9 - DIRECTOR_APPOINTED: Brenda Cooperstone seat on Lexeo Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:director_appointed:87b06n - DIRECTOR_APPOINTED: Paula HJ Cholmondeley seat on Lexeo Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:director_appointed:17ehuc3 - DIRECTOR_APPOINTED: Mette Kirstine Agger seat on Lexeo Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:director_appointed:19397x9 - DIRECTOR_APPOINTED: Steven Altschuler seat on Lexeo Therapeutics, Inc., effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:director_appointed:14j32vd - DIRECTOR_APPOINTED: Reinaldo Diaz seat on Lexeo Therapeutics, Inc., effective 2005-01-01. Effective: 2005-01-01. Detected: 2026-10-06T04:46:47.792621+00:00. event_id=alpha:event:director_appointed:elp594 ## Scoped resources - `alpha://company/lexeo-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record - `alpha://company/lexeo-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=identity - `alpha://company/lexeo-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/lexeo-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=board - `alpha://company/lexeo-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=committees - `alpha://company/lexeo-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=leadership - `alpha://company/lexeo-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=ownership - `alpha://company/lexeo-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=financials - `alpha://company/lexeo-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/lexeo-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=compensation - `alpha://company/lexeo-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=governance - `alpha://company/lexeo-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/lexeo-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=audit - `alpha://company/lexeo-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=legal - `alpha://company/lexeo-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=risk - `alpha://company/lexeo-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=cyber - `alpha://company/lexeo-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/lexeo-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=agents - `alpha://company/lexeo-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/lexeo-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=events - `alpha://company/lexeo-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=relationships - `alpha://company/lexeo-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=assessments - `alpha://company/lexeo-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Steven Altschuler, M.D.: Chairman of the Board. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a. - Brenda Cooperstone: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768. - Brenda Cooperstone, M.D.: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a. - Laura Sepp-Lorenzino: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:8. Valid from: 2026-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768. - Laura Sepp-Lorenzino, Ph.D.: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a. - Mette Kirstine Agger: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768. - Paula HJ Cholmondeley: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768. - R. Nolan Townsend: Chief Executive Officer and Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a. - Reinaldo Diaz: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:13. Valid from: 2005-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768. - Steven Altschuler: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:14. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768. - Tim Van Hauwermeiren: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:15. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768. - Tolga Tanguler: Director. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:16. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768. - Eric Adler, M.D.: Chief Medical Officer and Head of Research. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3ab2cb03e53d92d9abae1690968f032ec1e8564c610ddf7cdbe3b144b2380b37. - Jenny R. Robertson, J.D.: Chief Legal Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b431248d212628f79ffcdbc09a9f9e89154eb83634f6666950ce06f90e9866b4. - Jose Manuel Otero: Chief Operating Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:19. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b04799cf8924abdf20a384f0921dfff7b5962cc0225ebf2d7e87697bc1acf105. - Jose Manuel Otero, Ph.D.: Chief Operating Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a. - Kyle Rasbach, Ph.D.: Chief Financial Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a1c50cf983234c6852719ce5b25dd82452f7e0168f780cc47410b1fb57991b6c. - Louis Tamayo: Chief Financial Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a. - Narinder Bhalla, M.D.: Chief Medical Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a. - Narinder P. Bhalla: Chief Medical Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:24. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:52c67b99d38d82ebac0d60b0a3fc2cf97c6fddb9233c410f1573045ed43a8dec. - R. Nolan Townsend: Chief Executive Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a. - Sandi See Tai, M.D.: Chief Development Officer. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5365c198fc2286a3609d376016fb9cd919b1da1d77be34ce2dd3b213baae5c98. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Lexeo Therapeutics, Inc.. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:829efd97bd32eb6cbaa8de2505fba255d23c2f2f57ddca7649ecf862f04f80bb. ## Entity Status - Public listing published. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:829efd97bd32eb6cbaa8de2505fba255d23c2f2f57ddca7649ecf862f04f80bb. ## Published Fact - US. Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:829efd97bd32eb6cbaa8de2505fba255d23c2f2f57ddca7649ecf862f04f80bb. ## Security Listing - LXEO (NASDAQ). Claim: alpha:claim:company:ccd9516a-edef-493f-bd8d-d27dcc94d3c5:security_listing:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:829efd97bd32eb6cbaa8de2505fba255d23c2f2f57ddca7649ecf862f04f80bb. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:829efd97bd32eb6cbaa8de2505fba255d23c2f2f57ddca7649ecf862f04f80bb: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/lexeo-therapeutics-inc). - alpha:projection-evidence:document:e60509d2bf955b50fdb91004babe2b06527f389b2040190e10265816b5ca7b0a: [SEC DEF 14A 0001193125-26-193930](https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm). - alpha:projection-evidence:document:c146d5ecb40ef4a2c9105e8809e99d1b1ad6b2f42acc3cf65d0840501c971768: [DEF 14A lxeo-def_14a-2026_proxy.htm](https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm). - alpha:projection-evidence:document:3ab2cb03e53d92d9abae1690968f032ec1e8564c610ddf7cdbe3b144b2380b37: LXEO executive roster source. - alpha:projection-evidence:document:b431248d212628f79ffcdbc09a9f9e89154eb83634f6666950ce06f90e9866b4: LXEO executive roster source. - alpha:projection-evidence:document:b04799cf8924abdf20a384f0921dfff7b5962cc0225ebf2d7e87697bc1acf105: [LXEO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm). - alpha:projection-evidence:document:a1c50cf983234c6852719ce5b25dd82452f7e0168f780cc47410b1fb57991b6c: LXEO executive roster source. - alpha:projection-evidence:document:52c67b99d38d82ebac0d60b0a3fc2cf97c6fddb9233c410f1573045ed43a8dec: [LXEO DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1907108/000119312526193930/lxeo-def_14a-2026_proxy.htm). - alpha:projection-evidence:document:5365c198fc2286a3609d376016fb9cd919b1da1d77be34ce2dd3b213baae5c98: LXEO executive roster source. ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/lexeo-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/lexeo-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/lexeo-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/lexeo-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-06T20:04:15.102942+00:00; recorded 2026-10-06T20:04:15.102942+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.